Estimate and 95% CI for decrease in the number of mixed plaques for an 1 µg/ml increase in serum adiponectin levels. Full model 5 (including all parameters) is shown in Table S2 of the supplement. *ad
Supporting tables. Table S1. Characteristics of the sample according to AF status, weighted according to the age and sex distribution in the study population (N = 210,867). Table S2. Partial Spearman
Four studies reporting the fold changes/max changes or fold changes of miRNAs and cTnI with time are displayed in the table. * T0 indicates 156±72 min after the onset of symptoms. †T0 indicates 5.24±1
